phenyl-n-tert-butylnitrone and Parkinson Disease, Secondary

phenyl-n-tert-butylnitrone has been researched along with Parkinson Disease, Secondary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altomare, C; de Candia, M; Fiorella, F; Labandeira-García, JL; Méndez-Álvarez, E; Rodríguez-Pallares, J; Sánchez-Iglesias, S; Soto-Otero, R; Varlamov, AV; Voskressensky, LG; Zaytsev, VP; Zubkov, FI1
Brundin, P; Emgârd, M; Karlsson, J; Rosenblad, C1
Earl, CD; Ferger, B; Kuschinsky, K; Oertel, WH; Spratt, C; Teismann, P1

Other Studies

3 other study(ies) available for phenyl-n-tert-butylnitrone and Parkinson Disease, Secondary

ArticleYear
2-Benzazepine nitrones protect dopaminergic neurons against 6-hydroxydopamine-induced oxidative toxicity.
    Archiv der Pharmazie, 2012, Volume: 345, Issue:8

    Topics: Animals; Benzazepines; Brain; Cell Count; Cells, Cultured; Cholinesterase Inhibitors; Cyclic N-Oxides; Disease Models, Animal; Dopaminergic Neurons; Inhibitory Concentration 50; Lipid Peroxidation; Mitochondria; Molecular Structure; Neuroprotective Agents; Nitrogen Oxides; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Primary Cell Culture; Protein Carbonylation; Structure-Activity Relationship

2012
Treatment with the spin-trap agent alpha-phenyl-N-tert-butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons.
    Brain research, 1998, Sep-14, Volume: 805, Issue:1-2

    Topics: Aging; Animals; Cell Survival; Cell Transplantation; Cells, Cultured; Cyclic N-Oxides; Dopamine; Female; Fetal Tissue Transplantation; Graft Survival; Mesencephalon; Neurons; Nitrogen Oxides; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Spin Labels; Substantia Nigra

1998
Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo.
    Naunyn-Schmiedeberg's archives of pharmacology, 1998, Volume: 358, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Body Weight; Cardiotonic Agents; Cyclic N-Oxides; Dopamine; Dopamine Agents; Drug Interactions; Free Radical Scavengers; Hydroxyl Radical; Locomotion; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nitrogen Oxides; Parkinson Disease, Secondary

1998